medigraphic.com

2004, Number 2

Next >>

Rev Hosp Jua Mex 2004; 71 (2)

El sexo del donador, ¿es un factor que influye en la evolución del trasplante cuando el receptor es de sexo diferente?

Hernández CE, Bazán BAF, González GAF

Language: Spanish
References: 16
Page: 47-49
PDF size: 48.07 Kb.


ABSTRACT

There are conditions that have a direct influence in the live of renal graft like HLA compatibility, source of donations, sensibility, age of receptor-donor and other. A retrospective study about the clinical records of 176 patients underwent a kidney transplant in the Juarez Hospital of Mexico was carried out. Patients were divided in groups with differences about sex between receptor-donor and groups with the same sex. There aren’t influence of the receptor-donor sex in the life of the graft.


REFERENCES

  1. Takemoto SK. Evaluation of the transplant recipient and donor. Current approaches to distributing organs. Curr Opin Nephrol Hypertens 1997; 6: 299.

  2. Katznelson S. Análisis de histocompatibilidad, prueba cruzada y asignación de los trasplantes de riñón procedentes de cadáver. En: Trasplante renal de Danovitch. 3ra. Ed. p. 39-61.

  3. Kasike BL. The evaluation of renal transplant candidates: clinical practice guidelines. J Am Soc Nephrol 1995; 6: 1.

  4. Cho CS, Hamawy MM, Knechtle SJ. CD40:CD154 interactions and allograft rejection. Curr Opin Organ Transplant 2000; 5: 105.

  5. Dai Z, Lakkis FG. The role of cytokines, CTLA-4 and co stimulation in transplant tolerance and rejection. Curr Opin Immunol 1999; 11(5): 504-8.

  6. Dallman MJ. Cytokines and transplantation: Th1/Th2 regulation of the immune response to solid organ transplants. Curr Opin Immunol 1995; 7: 632-43.

  7. Faichild PJ, Waldmann H. Dendritic and prospects for transplantation tolerance. Curr Opin Immunol 2000; 12: 52835.

  8. Harlan DM, Kirk AD. Promise of co stimulatory pathway modifying reagents for transplantation. Curr Opin Organ Transplant 2000; 5: 90-5.

  9. Kawai T, Sachs DH, Cosimi AB. Tolerance to vascularized organ allografts in large-animal models. Curr Opin Immunol 1999; 11(5): 516-20.

  10. Knechtle SJ. Knowledge about transplantation tolerance gained in primates. Curr Opin Immunol 2000; 12: 552-6.

  11. Kung L, Gourishankar S, Halloran PF. Molecular pharmacology of immunosuppressive agents in relation to their clinical use. Curr Opin Organ Transplant 2000; 5: 268-75.

  12. Mahalati K, Kahan BD. Advancing the art of immunosuppression with the science of pharmacology. Curr Opin Organ Transplant 2000; 5: 255-62.

  13. Martorell J. Aspectos inmunológicos. Rechazo e infección en el trasplante. En: Aguado JM. Infecciones en pacientes trasplantados. Madrid: Ed. Harcourt; 2000.

  14. Racusen LC, Solez K, Burdick JF. Kidney transplant rejection. New York: Marcel Decker; 1998.

  15. Sayegh MH, Turka LA. T cell co stimulatory pathways: promising novel target for immunosuppression and tolerance induction. J Am Soc Nephrol 1995; 6: 1143-5.

  16. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in trasplantation. Immunol Today 1994; 15: 32-8.




2020     |     www.medigraphic.com